J. Galipeau

M. Rudnicki, B. Knoppers, B. Williams-Jones, 2007, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.

J. Nalbantoglu, H. Li, J. Galipeau, 1999, Cancer research.

Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner1

Philippe M. Campeau, M. Basik, J. Galipeau, 2009, The Journal of Immunology.

The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy.

J. Galipeau, E. Waller, J. Roback, 2013, Biomaterials.

Regulatory B Cells Induce Formation of IL-10-Expressing T Cells in Mice with Autoimmune Neuroinflammation

Jiusheng Deng, S. Rangaraju, A. Pennati, 2016, The Journal of Neuroscience.

Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.

A. Ducharme, B. Annabi, J. Tanguay, 2008, Cardiovascular research.

TGFβ secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect

J. Galipeau, C. Penafuerte, 2008, Cancer Immunology, Immunotherapy.

Gene Therapy for the Treatment of Cancer

J. Galipeau, H. Spencer, 2004 .

Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells

J. Galipeau, N. Eliopoulos, C. Beauséjour, 2002, Gene Therapy.

The nonapoptotic pathway mediating thymidine kinase/ganciclovir toxicity is reduced by signal from adenovirus type 5 early region 4.

G. Batist, J. Galipeau, S. Yuan, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Brief Report A Novel Parasite-Derived Suicide Gene for Cancer Gene Therapy with Specificity for Lung Cancer Cells

G. Batist, J. Galipeau, M. Alaoui-Jamali, 2001 .

A novel parasite-derived suicide gene for cancer gene therapy with specificity for lung cancer cells.

G. Batist, J. Galipeau, M. Alaoui-Jamali, 2001, Human gene therapy.

Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense.

P. Brodt, J. Galipeau, D. Jaalouk, 2001, Human gene therapy.

Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells.

J. Galipeau, D. Jaalouk, N. Eliopoulos, 2000, Human gene therapy.

Vesicular Stomatitis Virus G Pseudotyped Retrovector Mediates Effective in Vivo Suicide Gene Delivery in Experimental Brain Cancer 1

J. Nalbantoglu, J. Galipeau, A. Paquin, 1999 .

Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.

G. Gibson, D. Arafat, J. Galipeau, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mesenchymal stromal cells for the treatment of autoimmune diseases

J. Galipeau, C. N. Lewis, 2016 .

Perspectives of the International Society of Cell & Gene Therapy Gastrointestinal Scientific Committee on the Intravenous Use of Mesenchymal Stromal Cells in Inflammatory Bowel Disease (PeMeGi).

C. Klersy, C. D. dos Santos, R. Ciccocioppo, 2019, Cytotherapy.

X-linked genes exhibit miR6891-5p-regulated skewing in Sjögren’s syndrome

J. Galipeau, Wei Zhang, R. H. Scofield, 2022, Journal of Molecular Medicine.

Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation.

J. Galipeau, Y. Monczak, F. Mercier, 2009, Experimental hematology.

Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia.

D. Coutu, J. Galipeau, L. Chalifour, 2008, American journal of physiology. Renal physiology.

A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice

K. Lachapelle, J. Galipeau, N. Eliopoulos, 2003, Gene Therapy.

Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion

G. Gibson, Ronghu Wu, I. Sanz, 2018, Nature Communications.

The human ortholog of granulocyte macrophage colony-stimulating factor and interleukin-2 fusion protein induces potent ex vivo natural killer cell activation and maturation.

J. Routy, J. Galipeau, C. Penafuerte, 2009, Cancer research.

Mesenchymal Stromal Cells as Effective Tumor Antigen‐Presenting Cells in Cancer Therapeutics

R. Romieu-Mourez, J. Galipeau, 2013 .

Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.

J. Galipeau, R. Gagnon, N. Eliopoulos, 2006, Journal of the American Society of Nephrology : JASN.

Disruption of NF-κB Signaling and Chemokine Gene Activation by Retroviral Mediated Expression of IKKγ/NEMO Mutants

J. Hiscott, J. Galipeau, A. Paquin, 2001 .

Monocyte Derivatives Promote Angiogenesis and Myocyte Survival in a Model of Myocardial Infarction

E. Schiffrin, J. Routy, J. Galipeau, 2010, Cell transplantation.

Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence

B. Blok, J. Galipeau, J. Corcos, 2011, Neurourology and urodynamics.

Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases.

S. Yakar, P. Brodt, J. Burnier, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Loss of Tumorigenicity and Metastatic Potential in Carcinoma Cells Expressing the Extracellular Domain of the Type 1 Insulin-Like Growth Factor Receptor

E. Chevet, P. Brodt, J. Galipeau, 2004, Cancer Research.

Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice.

B. Sorrentino, J. Galipeau, K. D. Bunting, 1998, Blood.

Pancreatic Stellate Cells Prolong Ex Vivo Islet Viability and Function and Improve Engraftment

J. Galipeau, A. Balamurugan, P. Paul, 2022, Stem cells translational medicine.

Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction.

E. Schiffrin, J. Galipeau, V. Michaud, 2011, Cytokine.

immunoglobulin production via STAT3 inactivation and PAX5 induction derived CCL2 suppresses plasma cell - Mesenchymal stromal cell

M. Tremblay, B. Annabi, J. Galipeau, 2013 .

immunoglobulin production via STAT3 inactivation and PAX5 induction Mesenchymal stromal cell derived CCL2 suppresses plasma cell

M. Tremblay, B. Annabi, J. Galipeau, 2013 .

Mesenchymal Stromal Cell Derived CCL2 Suppresses Plasma Cell Immunoglobulin Production via STAT3 Inactivation and PAX5 Induction Running title: Plasmocyte Inhibition by Stromal Cells

M. Tremblay, B. Annabi, J. Galipeau, 2008 .

Mesenchymal stromal cell – derived CCL 2 suppresses plasma cell immunoglobulin production via STAT 3 inactivation and PAX 5 induction

M. Tremblay, B. Annabi, J. Galipeau, 2008 .

Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.

M. Tremblay, B. Annabi, J. Galipeau, 2008, Blood.

Galectin 3‐binding protein is a potential contaminant of recombinantly produced factor IX

M. Blostein, J. Galipeau, J. Cuerquis, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease.

J. Galipeau, R. Chinnadurai, Spencer Ng, 2015, World journal of gastroenterology.

GMCSF‐Interleukin fusion cytokines induce novel immune effectors that can serve as biopharmaceuticals for treatment of autoimmunity and cancer

J. Galipeau, P. Williams, 2011, Journal of internal medicine.

Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients.

Philippe M. Campeau, J. Galipeau, M. Rafei, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

for Immune Modulation Based Fusion Cytokines as Ligands - GM-CSF

J. Galipeau, P. Williams, 2013 .

Integrin Expression by NK Cells Killer Cell Lectin-Like Receptor 1 and Induction of Cardiac Angiogenesis Requires

E. Schiffrin, J. Galipeau, V. Michaud, 2010 .

Unique molecular characteristics and microglial origin of Kv1.3 channel–positive brain myeloid cells in Alzheimer’s disease

A. Levey, N. Seyfried, E. Dammer, 2021, Proceedings of the National Academy of Sciences.

Evidence for Transcriptional Regulation of the Glucose‐6‐Phosphate Transporter by HIF‐1α: Targeting G6PT with Mumbaistatin Analogs in Hypoxic Mesenchymal Stromal Cells

M. Post, E. Rassart, B. Annabi, 2009, Stem cells.

Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis.

G. Batist, J. Galipeau, M. Alaoui-Jamali, 2000, Mutation research.

Reprogramming of B cells into regulatory cells with engineered fusokines.

Jiusheng Deng, J. Galipeau, 2012, Infectious disorders drug targets.

A Novel and Simplified Method of Culture of Human Blood-Derived Early Endothelial Progenitor Cells for the Treatment of Ischemic Vascular Disease

A. Quyyumi, E. Schiffrin, J. Routy, 2011, Cell transplantation.

Peripheral Regulatory B Cell Phenotype in Multiple Sclerosis Patients

Jiusheng Deng, A. Pennati, J. Galipeau, 2012 .

A Fusion of GMCSF and IL-21 Initiates Hypersignaling Through the IL-21Rα Chain With Immune Activating and Tumoricidal Effects In Vivo.

Jennifer F. Raven, J. Galipeau, M. Rafei, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

A Fusion of GMCSF and IL-21 Initiates Hypersignaling Through the IL-21Rα Chain With Immune Activating and Tumoricidal Effects In Vivo.

Jennifer F. Raven, J. Galipeau, M. Rafei, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy.

P. López-Jaramillo, C. Morillo, M. Lalu, 2013, American heart journal.

Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential

I. Martin, S. Viswanathan, M. Krampera, 2020, Cytotherapy.

GIFT15 fusokine to foil immunity's follies.

J. Galipeau, M. Rafei, 2009, Immunotherapy.

The carboxylation efficiency of the vitamin K‐dependent clotting factors: studies with factor IX

S. Landry, M. Blostein, J. Galipeau, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Inducible IL10+ Suppressor B Cells Inhibit CNS Inflammation and T Helper 17 Polarization.

J. Galipeau, M. Rafei, E. Birman, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

A granulocyte-macrophage colony–stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties

C. Perreault, J. Galipeau, M. Rafei, 2009, Nature Medicine.

Development and Function of Innate Polyclonal TCRab CD8 Thymocytes

C. Perreault, J. Galipeau, M. Rafei, 2011 .

Enzyme replacement therapy in pediatric patients with Gaucher disease: what should we use as maintenance dosage?

G. Mitchell, J. Galipeau, M. Lambert, 2009, Molecular genetics and metabolism.

A STAT5-Smad3 dyad regulates adipogenic plasticity of visceral adipose mesenchymal stromal cells during chronic inflammation

J. Galipeau, W. Bushman, R. Chinnadurai, 2022, npj Regenerative Medicine.

Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome.

Philippe M. Campeau, J. Galipeau, M. Rafei, 2009, Blood.

A CCL2-based fusokine as a novel biopharmaceutical for the treatment of CCR2-driven autoimmune diseases.

J. Galipeau, M. Rafei, 2010, Critical reviews in immunology.

Induction of Increased Levels of Matrix Metalloproteinase-2 (MMP-2) and -9 in Human Breast Cancer Cell Lines by Activation of GM-CSF Receptor Bc via C-Fos-ERK 1/2 Signaling

M. Lalu, J. Galipeau, N. Eliopoulos, 2017 .

B effector cells activated by a chimeric protein consisting of IL-2 and the ectodomain of TGF-β receptor II induce potent antitumor immunity.

J. Galipeau, E. Birman, Spencer Ng, 2012, Cancer research.

CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury

J. Galipeau, E. Nylen, R. Chinnadurai, 2020, Cell reports.

Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience.

P. Hanley, C. Bollard, J. Galipeau, 2017, Cytotherapy.

Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells.

D. Martineau, L. Lejeune, J. Galipeau, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density.

R. Romieu-Mourez, J. Galipeau, M. Boivin, 2007, Journal of immunology.

Human Mesenchymal Stromal Cells Licensed − γ Effector Function by IFN-IDO-Independent Suppression of T Cell

J. Galipeau, R. Chinnadurai, I. Copland, 2014 .

A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells

L. Lejeune, J. Galipeau, D. Jaalouk, 2006, Virology Journal.

Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells.

S. Boyoglu-Barnum, L. Anderson, T. Hartert, 2017, Virology.

Minor salivary gland mesenchymal stromal cells derived from patients with Sjӧgren's syndrome deploy intact immune plasticity.

A. Pennati, J. Galipeau, P. Paul, 2020, Cytotherapy.

Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature.

I. Martin, S. Viswanathan, M. Krampera, 2019, Cytotherapy.

Potency Analysis of Mesenchymal Stromal Cells Using a Phospho‐STAT Matrix Loop Analytical Approach

J. Galipeau, P. Hematti, W. Bushman, 2019, Stem cells.

Molecular Genetic and Immune Functional Responses Distinguish Bone Marrow Mesenchymal Stromal Cells from Hepatic Stellate Cells

G. Gibson, D. Arafat, F. Anania, 2019, Stem cells.

Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers.

J. Galipeau, D. Phinney, 2019, Cytotherapy.

Image-Guided Transarterial Directed Delivery of Human Mesenchymal Stem Cells for Targeted Gastrointestinal Therapies in a Swine Model.

L. Brewster, J. Galipeau, S. Gumber, 2019, Journal of vascular and interventional radiology : JVIR.

Response to Nature commentary "Clear up this stem-cell mess".

J. Galipeau, M. Dominici, D. Weiss, 2019, Cytotherapy.

Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients

Scott T. Robinson, L. Brewster, J. Galipeau, 2018, Journal of vascular surgery.

Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B Cells

R. Redfield, J. Galipeau, N. Wilson, 2018, Transplantation direct.

Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.

G. Gibson, S. Kugathasan, D. Arafat, 2018, Cell reports.

Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T‐Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing

A. Kirk, J. Galipeau, E. Waller, 2016, Stem cells.

Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation

J. Galipeau, L. Krishnamurti, Elizabeth Stenger, 2015, BMC Immunology.

Allogeneic Versus Autologous Mesenchymal Stromal Cells and Donor-to-Donor Variability

J. Galipeau, M. Qayed, I. Copland, 2017 .

Dichotomic Potency of IFNγ Licensed Allogeneic Mesenchymal Stromal Cells in Animal Models of Acute Radiation Syndrome and Graft Versus Host Disease

L. Dewerd, K. Kunugi, J. Galipeau, 2021, Frontiers in Immunology.

Human mesenchymal stromal cells suppress T-cell proliferation independent of heme oxygenase-1.

J. Galipeau, R. Metz, I. Copland, 2015, Cytotherapy.

Defining mesenchymal stromal cells responsiveness to IFNγ as a surrogate measure of suppressive potency

J. Galipeau, R. Chinnadurai, 2014 .

Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis.

J. Galipeau, M. Rafei, E. Birman, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies.

R. Romieu-Mourez, D. Coutu, J. Galipeau, 2012, Frontiers in bioscience.

International stem cell environments: a world of difference

J. Illes, Jason Owen-Smith, Y. Joly, 2009 .

MSCs: science and trials

M. Krampera, J. Galipeau, Yufang Shi, 2013, Nature Medicine.

Mesenchymal Stromal Cells for Graft-versus-Host Disease: A Trilogy

J. Galipeau, 2020 .

Engineered fusokine GIFT4 licenses the ability of B cells to trigger a tumoricidal T-cell response.

Jiusheng Deng, A. Pennati, J. Galipeau, 2014, Cancer research.

Catalyzing umbilical cord blood research in Canada: a survey of current needs and practices of principal investigators.

B. Knoppers, E. Einsiedel, J. Galipeau, 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Properties of Immature Myeloid Progenitors with Nitric-Oxide-Dependent Immunosuppressive Activity Isolated from Bone Marrow of Tumor-Free Mice

J. Galipeau, E. Waller, W. Harris, 2013, PloS one.

New insights on translational development of mesenchymal stromal cells for suppressor therapy

J. Galipeau, M. François, 2012, Journal of cellular physiology.

Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming.

J. Medin, R. Romieu-Mourez, J. Galipeau, 2010, Cancer research.

Mesenchymal Stromal Cells Expressing ErbB-2/ neu Elicit Protective Antibreast Tumor Immunity In vivo , Which Is Paradoxically Suppressed by IFN- γ and Tumor Necrosis Factor- α Priming

J. Medin, J. Galipeau, E. Birman, 2010 .

Improving mesenchymal stem/stromal cell potency and survival: Proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congrès de Montréal, Organized by the ISCT MSC Scientific Committee.

J. Galipeau, J. Nolta, D. Phinney, 2020, Cytotherapy.

In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors.

J. Hiscott, D. Martineau, J. Galipeau, 2002, Cancer research.

Advances in Brief In Vivo Interferon Regulatory Factor 3 Tumor Suppressor Activity in B 16 Melanoma Tumors 1

J. Hiscott, D. Martineau, J. Galipeau, 2002 .

Islet allografts expressing a PD‐L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression

J. Galipeau, E. Nylen, P. Paul, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Selective Inhibition of CCR2 Expressing Lymphomyeloid Cells in Experimental Autoimmune Encephalomyelitis by a GM-CSF-MCP1 Fusokine1

Philippe M. Campeau, J. Galipeau, M. Rafei, 2009, The Journal of Immunology.

MT1-MMP Down-regulates the Glucose 6-Phosphate Transporter Expression in Marrow Stromal Cells

B. Annabi, J. Galipeau, Jian Cao, 2007, Journal of Biological Chemistry.

Actin Cytoskeletal Disruption following Cryopreservation Alters the Biodistribution of Human Mesenchymal Stromal Cells In Vivo

W. Lam, A. Kirk, J. Galipeau, 2014, Stem cell reports.

IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.

J. Galipeau, E. Waller, J. Roback, 2012, Blood.

Independent mechanisms underlie the protective effect of dietary polyunsaturated fatty acid supplementation and Gαz deficiency on the early type 1 diabetes phenotype of Non-obese diabetic (NOD) mice

A. Pennati, J. Galipeau, M. Kimple, 2021, bioRxiv.

Mesenchymal Stem Cells: From Bench to Bedside and Back

J. Galipeau, J. Barrett, 2018, Advances and Controversies in Hematopoietic Transplantation and Cell Therapy.

Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells

J. Allay, B. Sorrentino, Raymond L. Blakley, 1998, Stem Cells.

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry

K. Tarte, M. Lalu, S. Viswanathan, 2022, Cytotherapy.

An ISCT MSC Committee Editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for COVID-19: Time for a global registry

K. Tarte, M. Lalu, S. Viswanathan, 2022, Cytotherapy.

Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential TaggedEnd

S. Viswanathan, M. Krampera, J. Galipeau, 2022 .

Role of Virus-Speci ﬁ c T Cell Therapy for Cytomegalovirus and BK Infections in Kidney Transplant Recipients

J. Galipeau, S. Parajuli, A. Djamali, 2021 .

Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies

L. Bernal-Mizrachi, H. Khoury, J. Galipeau, 2013, Cancer.

Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia B.

A. Yousefi, M. Blostein, Rouwayda El Ayoubi, 2011, Biomaterials.

Improved Autograft Survival of Mesenchymal Stromal Cells by Plasminogen Activator Inhibitor 1 Inhibition

B. Annabi, D. Coutu, J. Galipeau, 2009, Stem cells.

Washed equine platelet extract (WEPLEX) as an anti-inflammatory biologic pharmaceutical.

A. Pennati, J. Galipeau, S. Brounts, 2020, Tissue engineering. Part A.

The Stem Cell Research Environment: A Patchwork of Patchworks

Judy Illes, Christine Critchley, Yann Joly, 2009, Stem Cell Reviews and Reports.

Innate immune responses of equine monocytes cultured in equine platelet lysate.

J. Galipeau, J. Peroni, I. Copland, 2018, Veterinary immunology and immunopathology.

Tissue Engineering of Rat Bladder Using Marrow-Derived Mesenchymal Stem Cells and Bladder Acellular Matrix

D. Coutu, J. Galipeau, J. Corcos, 2014, PloS one.

The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease – a phase 1 trial with three doses

S. Kugathasan, J. Galipeau, R. Chinnadurai, 2016, Alimentary pharmacology & therapeutics.

The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

Jacques Galipeau, J. Galipeau, 2013, Cytotherapy.

Death and inflammation following somatic cell transplantation

J. Galipeau, I. Copland, 2011, Seminars in Immunopathology.

Challenges for mesenchymal stromal cell therapies

I. Martin, J. Galipeau, K. Le Blanc, 2019, Science Translational Medicine.

A Fusion Cytokine Coupling GMCSF to IL9 Induces Heterologous Receptor Clustering and STAT1 Hyperactivation through JAK2 Promiscuity

J. Galipeau, S. Yuan, Pingxin Li, 2013, PloS one.

Roles of FGF signaling in stem cell self-renewal, senescence and aging

D. Coutu, J. Galipeau, 2011, Aging.

Three‐dimensional porous scaffolds at the crossroads of tissue engineering and cell‐based gene therapy

A. Yousefi, D. Coutu, J. Galipeau, 2009, Journal of cellular biochemistry.

Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy.

G. Gibson, S. Kugathasan, D. Arafat, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

From Single Nucleotide Polymorphisms to Constant Immunosuppression: Mesenchymal Stem Cell Therapy for Autoimmune Diseases

A. Nooka, J. Galipeau, E. Waller, 2013, BioMed research international.

The N-terminal of the estrogen receptor (ERα) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells

S. Mader, W. Miller, M. Couture, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.

Jacques Galipeau, R. Romieu-Mourez, J. Galipeau, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cells

J. Galipeau, S. Bosinger, R. Chinnadurai, 2017, Oncotarget.

Hypoxia Promotes Murine Bone‐Marrow‐Derived Stromal Cell Migration and Tube Formation

R. Béliveau, B. Annabi, J. Galipeau, 2003, Stem cells.

Green fluorescent protein in retroviral vector constructs as marker and reporter of gene expression for cell and gene therapy applications.

J. Galipeau, N. Eliopoulos, 2002, Methods in molecular biology.

Molecular and Endocrine Mechanisms Underlying the Stem Cell Theory of Aging

D. Coutu, J. Galipeau, 2014 .

A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs.

B. Sorrentino, Raymond L. Blakley, J. Galipeau, 1997, Human gene therapy.

Coding region-specific destabilization of mRNA transcripts attenuates expression from retroviral vectors containing class 1 aldehyde dehydrogenase cDNAs.

A. Townsend, B. Sorrentino, Raymond L. Blakley, 1997, Human gene therapy.

Effects of Retroviral‐Mediated MDR1 Expression on Hematopoietic Stem Cell Self‐Renewal and Differentiation in Culture a

B. Sorrentino, J. Galipeau, E. Benaim, 1999, Annals of the New York Academy of Sciences.

Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies

R. Foley, D. Spaner, J. Galipeau, 2008, Oncogene.

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice.

L. Lejeune, J. Galipeau, N. Eliopoulos, 2005, Blood.

BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth

S. Lonial, Jiusheng Deng, J. Kaufman, 2016, Oncotarget.

Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors

P. Brodt, J. Galipeau, D. Jaalouk, 2006, Virology Journal.

Retroviral Delivery of Connexin Genes to Human Breast Tumor Cells Inhibits in Vivo Tumor Growth by a Mechanism That Is Independent of Significant Gap Junctional Intercellular Communication*

Qing Shao, Jacques Galipeau, D. Laird, 2002, The Journal of Biological Chemistry.

Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy.

D. Martineau, J. Galipeau, M. Boivin, 2008, Cancer research.

Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy.

L. Lejeune, J. Galipeau, A. Paquin, 2004, Human gene therapy.

Periostin, a Member of a Novel Family of Vitamin K-dependent Proteins, Is Expressed by Mesenchymal Stromal Cells*

M. Blostein, D. Coutu, J. Galipeau, 2008, Journal of Biological Chemistry.

Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats.

S. Archer, G. Korbutt, B. Thébaud, 2009, American journal of respiratory and critical care medicine.

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

Ivan Martin, John Barrett, Donald G Phinney, 2016, Cytotherapy.

The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria.

Jacques Galipeau, M. Krampera, J. Galipeau, 2015, Cytotherapy.

Concerns arising from MSC retrieval from cryostorage and effect on immune suppressive function and pharmaceutical usage in clinical trials

J. Galipeau, 2013 .

Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo

K. Lachapelle, D. Martineau, L. Lejeune, 2003, Gene Therapy.

Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.

R. Béliveau, J. Nalbantoglu, B. Annabi, 2005, Cancer research.

Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.

J. Galipeau, M. Qayed, E. Waller, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells.

D. Coutu, J. Galipeau, M. François, 2011, Blood.

Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation.

J. Galipeau, J. Stagg, 2013, Current molecular medicine.

Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.

R. Romieu-Mourez, J. Galipeau, M. Boivin, 2009, Blood.

Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell.

J. Galipeau, N. Eliopoulos, J. Stagg, 2006, Blood.

[The use of mesenchymal stromal cells in oncology and cell therapy].

J. Galipeau, S. Pommey, 2006, Bulletin du cancer.

Mesenchymal Stem Cells and Tissue Repair

D. Coutu, J. Galipeau, M. François, 2012 .

Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis

Jeffrey A. Cohen, H. Atkins, A. Bar-Or, 2010, Annals of neurology.

Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages.

D. Shum-Tim, J. Galipeau, D Shum-Tim, 2000, The Journal of thoracic and cardiovascular surgery.

A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization.

Scott T. Robinson, T. Barker, Haiyan Li, 2016, Acta biomaterialia.

Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review.

J. Galipeau, P. Ghali, Majid Abdulrahman Almadi, 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Maltose-Binding Protein Fusion Allows for High Level Bacterial Expression and Purification of Bioactive Mammalian Cytokine Derivatives

Jiusheng Deng, A. Pennati, J. Galipeau, 2014, PloS one.

Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal Cells.

C. Bruker, J. Galipeau, R. Chinnadurai, 2021, Transplantation and cellular therapy.

Transcriptional Regulation of the TFIIH Transcription Repair Components XPB and XPD by the Hepatitis B Virus x Protein in Liver Cells and Transgenic Liver Tissue*

B. Slagle, J. Galipeau, M. Alaoui-Jamali, 2001, The Journal of Biological Chemistry.

FIST, a sword and shield fusokine for cancer immunotherapy

J. Galipeau, C. Penafuerte, 2012, Oncoimmunology.

Cell-based therapeutic strategies for multiple sclerosis

Jeffrey A. Cohen, H. Atkins, S. Reingold, 2017, Brain : a journal of neurology.

Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial.

M. Kutryk, D. Stewart, J. Granton, 2015, Circulation research.

GIFT4 fusokine converts leukemic B cells into immune helper cells

C. Flowers, Jiusheng Deng, A. Pennati, 2016, Journal of Translational Medicine.

B cells for cancer immunotherapy

Jiusheng Deng, J. Galipeau, 2014, Oncoimmunology.

A Dendritic Cell Population Generated by a Fusion of GM-CSF and IL-21 Induces Tumor-Antigen–Specific Immunity

R. Romieu-Mourez, J. Galipeau, M. Rafei, 2010, Journal of Immunology.

A GMCSF and IL7 fusion cytokine leads to functional thymic-dependent T-cell regeneration in age-associated immune deficiency

J. Galipeau, Jian Hui Wu, G. Tharp, 2015, Clinical & translational immunology.

Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease

J. Galipeau, M. Qayed, E. Waller, 2022, Frontiers in Immunology.

Connexin Over-Expression Differentially Suppresses Glioma Growth and Contributes to the Bystander Effect Following HSV-Thymidine Kinase Gene Therapy

C. Naus, J. Galipeau, D. Belliveau, 2006, Cell communication & adhesion.

Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.

Jiusheng Deng, A. Pennati, J. Galipeau, 2016, Cancer research.

A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex.

Borhane Annabi, Jacques Galipeau, B. Annabi, 2006, Blood.

B. Annabi, L. Lejeune, J. Galipeau, 2006 .

Enabling Technologies for Cell-Based Clinical Translation Concise Review : Engineering the Fusion of Cytokines for the Modulation of Immune Cellular Responses in Cancer and Autoimmune Disorders

J. Galipeau, Spencer Ng, N. Spencer, 2014 .

Neuronal Differentiation and Growth Control of Neuro-2a Cells After Retroviral Gene Delivery of Connexin43*

D. Lidington, D. Laird, J. Galipeau, 2000, The Journal of Biological Chemistry.

Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells.

K. Tarte, M. Krampera, J. Galipeau, 2012, Cell stem cell.

Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model.

Jacques Galipeau, H. Al-Sabti, K. Lachapelle, 2003, The Annals of thoracic surgery.

Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells.

R. Béliveau, B. Annabi, J. Galipeau, 2003, Experimental hematology.

CTR9 drives osteochondral lineage differentiation of human mesenchymal stem cells via epigenetic regulation of BMP-2 signaling

Wan-Ju Li, J. Galipeau, Yidan Wang, 2022, Science advances.

Regulation of MHC Class II Expression and Antigen Processing in Murine and Human Mesenchymal Stromal Cells by IFN-γ, TGF-β, and Cell Density1

R. Romieu-Mourez, J. Galipeau, M. Boivin, 2007, The Journal of Immunology.

Tetra- and hexavalent mannosides inhibit the pro-apoptotic, antiproliferative and cell surface clustering effects of concanavalin-A: impact on MT1-MMP functions in marrow-derived mesenchymal stromal cells.

B. Annabi, J. Galipeau, R. Roy, 2007, Glycobiology.

Mouse P-selectin glycoprotein ligand-1: molecular cloning, chromosomal localization, and expression of a functional P-selectin receptor.

C. Kozak, B. Furie, J. Galipeau, 1996, Blood.

Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products.

Patricia J. Zettler, B. Levine, R. Ciccocioppo, 2022, Cytotherapy.

Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction.

M. Taljaard, M. Ward, M. Kutryk, 2010, American heart journal.

Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs

Jiusheng Deng, R. Compans, J. Galipeau, 2015, Scientific Reports.

Parathyroid hormone-related protein promotes quiescence and survival of serum-deprived chondrocytes by inhibiting rRNA synthesis.

E. Petroulakis, J. Galipeau, J. Henderson, 2001, The Journal of biological chemistry.

A MCP1 fusokine with CCR2-specific tumoricidal activity

T. MacDonald, Jiusheng Deng, L. Boise, 2011, Molecular Cancer.

blood flow in a chronic limb ischemia model Therapeutic angiogenesis using autologous bone marrow stromal cells: improved

H. Al-Sabti, K. Lachapelle, J. Galipeau, 2013 .

Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors

Borhane Annabi, Jacques Galipeau, B. Annabi, 2004, Journal of cellular biochemistry.

CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization.

D. Stewart, K. Lachapelle, Peter P. Liu, 2008, Experimental hematology.

Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy

J. Galipeau, Jian Hui Wu, J. Stagg, 2004, Cancer Research.

Cooperation of Matrix Metalloproteinases with the RhoA/Rho Kinase and Mitogen‐Activated Protein Kinase Kinase‐1/Extracellular Signal‐Regulated Kinase Signaling Pathways Is Required for the Sphingosine‐1‐Phosphate‐Induced Mobilization of Marrow‐Derived Stromal Cells

B. Annabi, L. Lejeune, J. Galipeau, 2006, Stem cells.

Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy.

G. Batist, D. Laird, J. Galipeau, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells

Ronghu Wu, J. Galipeau, C. Joyner, 2018, Journal of extracellular vesicles.

Ruxolitinib Inhibits IFNγ-stimulated Sjögren's Salivary Gland MSC HLA-DR Expression and Chemokine-Dependent T-cell Migration.

A. Pennati, J. Galipeau, Rahul Das, 2022, Rheumatology.

Design and fabrication of 3D porous scaffolds to facilitate cell-based gene therapy.

Rouwayda El-Ayoubi, Jacques Galipeau, A. Yousefi, 2008, Tissue engineering. Part A.

Mesenchymal Stem Cells for Vascular Target Discovery in Breast Cancer-Associated Angiogenesis

J. Galipeau, 2004 .

Adoptive transfer of IL-10+ regulatory B cells decreases myeloid-derived macrophages in the central nervous system in a transgenic amyotrophic lateral sclerosis model

J. Glass, A. Pennati, J. Galipeau, 2018, Cellular & Molecular Immunology.

Adoptive transfer of mesenchymal stromal cells accelerates intestinal epithelium recovery of irradiated mice in an interleukin-6-dependent manner.

L. Gaboury, J. Galipeau, E. Birman, 2012, Cytotherapy.

Reply: “Function of Cryopreserved Mesenchymal Stromal Cells With and Without Interferon‐γ Prelicensing Is Context Dependent”

J. Galipeau, 2017, Stem Cells.

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue-derived MSCs for research purposes.

K. Tarte, M. Lalu, Georges Dagher, 2023, Cytotherapy.

Author Correction: Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion

G. Gibson, Ronghu Wu, I. Sanz, 2019, Nature Communications.

TITLE : Genetically Engineered Autologous Cells for Antiangiogenic Therapy of Breast Cancer

J. Galipeau, D. Ph., Nicoletta Eliopoulos, 2022 .

GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.

Jiusheng Deng, A. Pennati, J. Galipeau, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.